Abstract
Diagnostic methods are limited for detecting microscopic soft tissue metastases in patients with prostate cancer. Previous studies using 111Indium Capromab Pendetide (ProstaScint™ scan) analyzed patients with extensive localized tumor (prostate specific antigen (PSA) >20 ng/ml) not optimal for surgical therapy. We evaluated the role of the ProstaScint™ scan in a preoperative population to provide histological documentation and to assess its utility in a surgical population. A total of 22 preoperative patients, underwent a ProstaScint™ scan. The mean preoperative PSA was 16.0 ng/ml (range 3.9–33 ng/ml). The mean Gleason score at biopsy was 6.9 (range 6–9). Each patient underwent a radical retropubic prostatectomy and bilateral pelvic lymph node dissection, which included resection of both obturator and common iliac lymph nodes. Histologic analysis of the resected lymph nodes provided the standard of comparison with the ProstaScint™ scan. The results of the scan and pathology for all 22 patients were compared with the bilateral obturator and iliac nodes, creating 88 data points. Nine areas (10%) were positive on the scan. One of these (11%) was a true positive while the other eight (89%) were false positives. Seventy-nine areas (90%) were negative on scan results. Of these, five areas (6%) were false negatives and 74 areas (94%) were true negatives. The scan yielded a sensitivity of 17%, specificity of 90%, negative predictive value (NPV) of 94% and a positive predictive value (PPV) of 11%. The high false positive rate and low PPV of ProstaScint scans overestimates metastatic lymph nodes disease, and is not useful when used preoperatively.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Ellis RJ et al. Radioimmunoguided imaging of prostate cancer foci with histopathologic correlation Int J Radiation Oncol Biol Phys 2001 49: 1281–1286
Sartor O, McLeod D . Indium-111-capromab pendetide scans: an important test relevant to clinical decision making Urology 2001 57: 399–401
Elgamal AA, Troychak MJ, Murphy GP . ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients Prostate 1998 37: 261–269
Kahn D et al. 111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy J Urol 1998 159: 2041–2046
Hinkle GH et al. Multicenter radioimmunoscintigraphic evaluation of patients with primary prostate cancer using indium in-111 capromab pendetide Cancer 1998 83: 739–747
Polascik TJ et al. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients Cancer 1999 85: 1586–1592
Manyak et al. Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer Urology 1999 54: 1058–1063
Babaian RJ et al. Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356 J Urol 1994 152: 1952–1955
Lamb HM, Faulds D . Capromab pendetide: a review of its use as an imaging agent in prostate cancer Drugs Aging 1998 12: 293–304
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ponsky, L., Cherullo, E., Starkey, R. et al. Evaluation of preoperative ProstaScint™ scans in the prediction of nodal disease. Prostate Cancer Prostatic Dis 5, 132–135 (2002). https://doi.org/10.1038/sj.pcan.4500570
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.pcan.4500570
Keywords
This article is cited by
-
18F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer
World Journal of Urology (2014)
-
Individualized image-based lymph node irradiation for prostate cancer
Nature Reviews Urology (2013)
-
Extended lymph node dissection for prostate cancer
Current Urology Reports (2008)
-
Technology Insight: monoclonal antibody imaging of prostate cancer
Nature Clinical Practice Urology (2006)